PMVP NASDAQ
PMV Pharmaceuticals, Inc.
1W: +34.6%
1M: +42.1%
3M: +47.9%
YTD: +45.5%
1Y: +31.6%
3Y: -71.0%
5Y: -93.9%
$1.79
+0.04 (+2.29%)
Weekly Expected Move ±11.8%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — PMVP
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (21)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 50.0 | 62.0 | 64.7 | 58.9 | SEC ↗ |
| 2026-03-31 | 10-Q | 56.0 | 64.6 | 66.6 | 62.4 | SEC ↗ |
| 2025-12-31 | 10-K | 60.7 | 59.3 | 64.2 | 61.4 | SEC ↗ |
| 2025-09-30 | 10-Q | 49.8 | 62.9 | 67.7 | 60.1 | SEC ↗ |
| 2025-06-30 | 10-Q | 50.6 | 63.4 | 64.7 | 59.6 | SEC ↗ |
| 2025-03-31 | 10-Q | 46.9 | 64.5 | 68.8 | 60.1 | SEC ↗ |
| 2024-12-31 | 10-K | 60.8 | 60.1 | 63.7 | 61.5 | SEC ↗ |
| 2024-09-30 | 10-Q | 61.5 | 62.6 | 69.1 | 64.4 | SEC ↗ |
| 2024-06-30 | 10-Q | 67.9 | 63.8 | 67.7 | 66.5 | SEC ↗ |
| 2024-03-31 | 10-Q | 61.7 | 62.1 | 67.8 | 63.9 | SEC ↗ |
| 2023-09-30 | 10-Q | 58.2 | 63.0 | 67.0 | 62.7 | SEC ↗ |
| 2023-06-30 | 10-Q | 58.4 | 63.0 | 71.7 | 64.4 | SEC ↗ |
| 2023-03-31 | 10-Q | 55.5 | 65.4 | 68.4 | 63.1 | SEC ↗ |
| 2022-12-31 | 10-K | 61.7 | 60.1 | 65.3 | 62.4 | SEC ↗ |
| 2022-06-30 | 10-Q | 58.4 | 63.5 | 70.0 | 64.0 | SEC ↗ |
| 2021-12-31 | 10-K | 59.8 | 60.9 | 65.1 | 61.9 | SEC ↗ |
| 2021-09-30 | 10-Q | 59.8 | 62.7 | 69.7 | 64.0 | SEC ↗ |
| 2021-06-30 | 10-Q | 59.6 | 57.7 | 63.8 | 60.3 | SEC ↗ |
| 2021-03-31 | 10-Q | 57.5 | 64.0 | 67.1 | 62.8 | SEC ↗ |
| 2020-12-31 | 10-K | 55.9 | 58.8 | 63.3 | 59.3 | SEC ↗ |
| 2020-09-30 | 10-Q | 59.8 | 59.7 | 64.5 | 61.4 | SEC ↗ |